MaxCyte Inc (MXCT)
NASDAQ:MXCT
Holding MXCT?
Track your performance easily

MaxCyte (MXCT) Financial Statements

57 Followers

MaxCyte Financial Overview

MaxCyte's market cap is currently ―. The company's EPS TTM is $-0.341; its P/E ratio is -10.47; MaxCyte is scheduled to report earnings on April 23, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 8.16M$ 10.43M$ 11.34M$ 15.66M$ 8.00M
Gross Profit$ 6.24M$ 8.94M$ 9.94M$ 14.09M$ 7.21M
EBIT$ -11.56M$ -9.38M$ -12.28M$ -8.10M$ -13.95M
EBITDA$ -10.37M$ -6.19M$ -11.16M$ -6.99M$ -12.87M
Net Income Common Stockholders$ -11.56M$ -9.38M$ -9.53M$ -5.28M$ -11.25M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 153.83M$ 157.33M$ 157.51M$ 168.29M$ 190.24M
Total Assets$ 248.61M$ 251.50M$ 257.93M$ 268.27M$ 266.73M
Total Debt$ 18.32M$ 18.53M$ 18.64M$ 18.74M$ 16.08M
Net Debt$ -135.51M$ -138.80M$ -138.87M$ -149.54M$ -174.16M
Total Liabilities$ 35.31M$ 30.23M$ 31.57M$ 36.11M$ 33.35M
Stockholders Equity$ 213.30M$ 221.26M$ 226.36M$ 232.17M$ 233.38M
Cash Flow-
Free Cash Flow$ -4.80M$ -5.13M$ -11.37M$ 66.90K$ -8.96M
Operating Cash Flow$ -4.39M$ -4.83M$ -10.56M$ 981.70K$ -8.24M
Investing Cash Flow$ 3.61M$ 19.39M$ -14.40M$ -4.14M$ 2.81M
Financing Cash Flow$ 228.00K$ 713.00K$ 703.00K$ 493.00K$ 36.70K
Currency in USD

MaxCyte Earnings and Revenue History

MaxCyte Debt to Assets

MaxCyte Cash Flow

MaxCyte Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis